Move Over Celgene Here Comes Nuvilex and $27 Million to Advance Its Pancreatic Cancer Clinical Trials
February 21, 2014 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Feb 21, 2014) - Nuvilex, Inc. (OTCQB: NVLX) just became relevant in the biotech industry. The company can now move forward with its clinical trials for the...
Nuvilex's Pancreatic Cancer Treatment Readies to Challenge Eli Lilly and Celgene in Late-Phase Clinical Trials
February 19, 2014 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Feb 19, 2014) - Nuvilex, Inc. (OTCQB: NVLX) is a small biotech firm in Silver Spring, Maryland, that hopes to soon be mentioned with much larger biotechnology and...
Congressional Legislators Agree With Nuvilex's Dr. Mark Rabe on Reclassifying Marijuana
February 14, 2014 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Feb 14, 2014) - Nuvilex, Inc.'s (OTCQB: NVLX) Dr. Mark L. Rabe has something in common with 18 members of Congress. All of them want marijuana reclassified from its...
Nuvilex's Dr. Mark Rabe Talks Medical Marijuana, Legalization and Cell-in-a-Box
February 12, 2014 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Feb 12, 2014) - Nuvilex, Inc. (OTCQB: NVLX) is a biotechnology company that's focused on getting into late phase clinical trials for the treatment of advanced,...
Nuvilex Expects to Continue Success of Cell-in-a-Box Technology with Marijuana-Based Treatments
February 10, 2014 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Feb 10, 2014) - If Nuvilex, Inc. (OTCQB: NVLX) can use the Cell-in-a-Box™ technology to develop marijuana-based treatments for cancer with the same success it has...
Medical Marijuana Could Bring Nuvilex and the National Football League Together
February 05, 2014 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Feb 5, 2014) - Nuvilex, Inc. (OTCQB: NVLX) entered the medical marijuana arena in 2013 as a biotech that would use its expertise to develop treatments for hard to treat...
Nuvilex, Inc.'s Marijuana Research and Treatments Get Closer With Banking Discussions
January 27, 2014 09:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 27, 2014) - Nuvilex, Inc. (OTCQB: NVLX) has emerged as a biotechnology firm that will develop treatments for both Cancer and Diabetes using the Cell-in-a-Box™...
Obama's Shifting Opinion Good News for Marijuana Industry and Nuvilex
January 21, 2014 09:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 21, 2014) - Nuvilex, Inc. (OTCQB: NVLX) executives had to perk up when they heard the news coming from The New Yorker magazine's interview with President Obama...
Nuvilex and Medical Marijuana Companies Keep an Eye on Florida as Crucial Swing State in Cannabis Debate
January 16, 2014 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 16, 2014) - Nuvilex, Inc. (OTCQB: NVLX) and a host of marijuana companies are keeping a close eye on what is happening with a petition drive in Florida to get the...
Nuvilex's Medical Marijuana Sciences Prepares to Enhance Industry's Research With Cell-in-a-Box(TM)
January 14, 2014 09:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 14, 2014) - While Nuvilex, Inc. (OTCQB: NVLX) continues to lay the foundation for its medical marijuana subsidiary, Medical Marijuana Sciences, Inc. (MMS), a growing...